Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/03/2002WO2002077011A2 Oxidation-reduction sensitive green fluorescent protein variants
10/03/2002WO2002077010A2 Method of preventing t-cell mediated responses by map proteins
10/03/2002WO2002077006A1 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
10/03/2002WO2002077001A2 Novel receptors
10/03/2002WO2002076510A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/03/2002WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002WO2002076489A1 Serum albumin binding moieties
10/03/2002WO2002076488A1 Human secreted proteins
10/03/2002WO2002076486A2 Histidine-rich glycoprotein
10/03/2002WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses
10/03/2002WO2002076482A2 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
10/03/2002WO2002076469A1 A novel technology of intracellular delivery of dna oligonucleotides to improve drug activity
10/03/2002WO2002076467A1 Compositions and methods to regulate bone and mineral metabolism
10/03/2002WO2002076448A1 Molecular conjugates for use in treatment of cancer
10/03/2002WO2002076389A2 Compositions and methods to prevent metastasis from primary malignancies
10/03/2002WO2002076380A2 Cytotoxic factors for modulating cell death
10/03/2002WO2002076204A2 Use of insect cell membrane transporters as novel target sites for insecticides
10/03/2002WO2002076195A1 Ras p27 animal models and uses thereof
10/03/2002WO2002076174A2 Fbh58295fl, a novel human amino acid transporter and uses thereof
10/03/2002WO2002076173A2 Inhibitors of glycosaminoglycans
10/03/2002WO2002068687A8 Function and application of tob gene in central nervous system of mammal
10/03/2002WO2002062944A3 Novel physiologically active peptide and use thereof
10/03/2002WO2002062297A3 Methods and compositions for modulating gluconeogenesis using pgc-1
10/03/2002WO2002059153A3 Anticoagulants and their uses
10/03/2002WO2002056828A3 Helper virus-free herpes virus amplicon particles and uses thereof
10/03/2002WO2002055533A3 Methods of using imxp-888 and imxp-888 antagonists
10/03/2002WO2002055109A3 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
10/03/2002WO2002054939A3 Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
10/03/2002WO2002051859A3 Haplotypes of the ptafr gene
10/03/2002WO2002046226A3 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
10/03/2002WO2002044376A9 Modulation of gene expression using insulator binding proteins
10/03/2002WO2002044206A3 Membrane fusion proteins derived from reovirus
10/03/2002WO2002043658A9 Fcrn-based therapeutics for the treatment of auto-immune disorders
10/03/2002WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002WO2002029073A3 Gene delivery vectors for stem cells
10/03/2002WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002WO2002024896A9 Screening assays for agonists or antagonists of receptor activat or of nf-kb
10/03/2002WO2002022677A3 Variants of allergenic proteins of the group 2 of dermatophagoides
10/03/2002WO2002018595A3 Moraxella polypeptides and corresponding dna fragments and uses thereof
10/03/2002WO2002018578A3 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
10/03/2002WO2002016422A3 Recombinant constructs of borrelia burgdorferi
10/03/2002WO2002012344A3 Methods for using 14266, a human g protein-coupled receptor
10/03/2002WO2002010195A3 Modified peptides with increased potency
10/03/2002WO2002004949A3 Reagents and methods for identification of binding agents
10/03/2002WO2002002751A3 Alteration of cell membrane
10/03/2002WO2002000902A3 Regulation of anthocyanin pigment production
10/03/2002WO2001098515A3 Gene-regulating conjugates
10/03/2002WO2001098355A3 Cgi-69 compositions and methods of use
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001092309A3 Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
10/03/2002WO2001090150A3 G protein-coupled receptors from human clone '26908' and uses thereof
10/03/2002WO2001083754A3 Cellular regulators of infectious agents and methods of use
10/03/2002WO2001083535A3 Polypeptides for use as a vaccine and/or treatment for hiv infection
10/03/2002WO2001074862A3 Method for the production of bacterial toxins
10/03/2002WO2001070976A3 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
10/03/2002WO2001023564A9 Secreted factors
10/03/2002WO2001023419A9 Differentially expressed genes
10/03/2002WO2001021794A9 Smad associating polypeptides
10/03/2002WO2001020989A9 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
10/03/2002WO2001019846A9 Transgenically produced fusion proteins
10/03/2002WO2001017343A9 Methods for evaluating a compound for its effect on skin
10/03/2002WO2001009177A3 Affinity fluorescent proteins and uses thereof
10/03/2002WO2000073502A3 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
10/03/2002WO2000069896A9 Molecular interactions in haematopoietic cells
10/03/2002WO1999064459A3 Gene encoding organic anion transporter
10/03/2002WO1999060106A3 A universal plant promoter inducible by low- temperatures
10/03/2002WO1999047923A3 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
10/03/2002US20020144310 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
10/03/2002US20020144309 Transgenic plants expressing MinD or MinE and an efficient method for plant chloroplast transformation and gene expression
10/03/2002US20020144308 Viral amplification of recombinant messenger RNA in transgenic plants
10/03/2002US20020144307 Plant defense-inducible genes and their use
10/03/2002US20020144306 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants
10/03/2002US20020144302 Expression vector coding protein for use in the treatment of liver disorders
10/03/2002US20020144300 Expression vector coding protein for use in the treatment of diabetes
10/03/2002US20020144299 Nuceotide sequences coding malarial surface protein for use in the treatment and prevention of malaria
10/03/2002US20020144298 Novel human genes and gene expression products
10/03/2002US20020144296 Transgenic animal for use in the generation of heterologous proteins in milk; for use in generation of disease and infection resistant pigs
10/03/2002US20020143207 Process for the deprotection of protected thiols
10/03/2002US20020143170 Bone morphogenic protein (BMP) polynucleotides, polypeptides, and antibodies
10/03/2002US20020143165 Nucleotide sequences coding polypeptide for use inthe treatment of nervous system disorders and stroke
10/03/2002US20020143164 Ras activator nucleic acid molecules, polypeptides and methods of use
10/03/2002US20020143163 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same, and applications thereof
10/03/2002US20020143161 Members of the d52 gene family
10/03/2002US20020143159 Bone morphogenetic protein (bmp)-17 and bmp-18 compositions
10/03/2002US20020143156 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system, vision, kidney and liver disorders
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143154 Protein for use in the diagnosis and treatment of tumors
10/03/2002US20020143152 Polypeptide for use in the treatment of hypercholesterolemia, hyperlipemia, diabetes, cancer, pancreatitis, bone, nervvous system, kidney and sexual disorders
10/03/2002US20020143151 Gaq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
10/03/2002US20020143149 Seven trans-membrane receptor-Fitz2
10/03/2002US20020143148 Polypeptide for use in human therapeutics and diagnostics
10/03/2002US20020143147 Mammalian genes; related reagents
10/03/2002US20020143146 Transport protein for use in the treatment and diagnosis of tumor
10/03/2002US20020143141 Cyclic peptide for use in the treatment of eating disorders
10/03/2002US20020142989 Oncolytic/immunogenic complementary-adenoviral vector system
10/03/2002US20020142988 G-coupled receptor showing selective affinity for ATP
10/03/2002US20020142987 Methods of inducing mucosal immunity
10/03/2002US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142979 Novel molecules of the card-related protein family and uses thereof
1 ... 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 ... 2916